logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Thomas H Marsilje, Iii

This inventor holds 15 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignees: Irm LLC, Dynamic Connections, LLC, Novartis Ag. Active years: 2006-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas H Marsilje, Iii. Retrieved from https://idiyas.com/inventor/thomas-h-marsilje-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 40.0

 

Average Co-Inventor Count = 6.1

ph-index = 7

Forward Citations = 156(Granted Patents)


Company Filing History:

goldMedal10 out of 152 
 
Irm LLC
 patents
silverMedal2 out of 2 
 
Dynamic Connections, LLC
 patents
bronzeMedal1 out of 3,978 
 
Novartis Ag
 patents
4. 1 out of 4 
 
Ore Pharmaceuticals Inc.
 patents
5. 1 out of 834,570 
Other
 patents

Years Active: 2006-2016

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9440957 - Compounds and compositions for modulating EGFR Activity (2016-09-13),
2. 8957081 - Compounds and compositions as protein kinase inhibitors (2015-02-17),
3. 8859574 - Compounds and compositions as kinase inhibitors (2014-10-14),
4. 8698031 - Separation and manipulation of a chiral object (2014-04-15),
5. 8592432 - Compounds and compositions as protein kinase inhibitors (2013-11-26),
6. 8519129 - Pyrimidine derivatives as kinase inhibitors (2013-08-27),
7. 8445505 - Pyrimidine derivatives as kinase inhibitors (2013-05-21),
8. 8440681 - 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors (2013-05-14),
9. 8399450 - Compounds and compositions as protein kinase inhibitors (2013-03-19),
10. 8377921 - Compounds and compositions as protein kinase inhibitors (2013-02-19),
11. 8372858 - Compounds and compositions as protein kinase inhibitors (2013-02-12),
12. 8039479 - Compounds and compositions as protein kinase inhibitors (2011-10-18),
13. 7935906 - Separation and manipulation of a chiral object (2011-05-03),
14. 7375125 - Melanocortin-4 receptor binding compounds and methods of use thereof (2008-05-20),
15. 7060697 - Immunosuppressant compounds and compositions (2006-06-13),

Title: The Inventive Journey of Thomas H Marsilje III

Introduction:

Thomas H Marsilje III, a prolific inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals through his innovative patented compounds and compositions. With an impressive total of 29 patents to his name, Marsilje's work revolves around modulating EGFR activity and developing novel protein kinase inhibitors.

Latest Patents:

Marsilje's latest patents showcase his dedication to advancing medical treatments. His inventions include compounds and compositions for modulating EGFR activity, which are vital in treating conditions associated with abnormal EGFR activity. Additionally, his work on protein kinase inhibitors opens up new possibilities for treating a range of diseases by targeting ALK, FAK, ZAP-70, IGF-1R, among others.

Career Highlights:

Having worked in reputable companies like Irm LLC and Dynamic Connections, LLC, Marsilje has honed his skills and expertise in the pharmaceutical industry. His journey as an inventor has been marked by a relentless pursuit of groundbreaking solutions to complex medical challenges.

Collaborations:

Collaboration plays a crucial role in Marsilje's success. With coworkers like Bei Chen and Wenshuo Lu, he has been able to exchange ideas, push boundaries, and bring his innovative concepts to fruition. The synergy created through collaborations has undoubtedly enhanced the quality of his inventions.

Conclusion:

Thomas H Marsilje III's impressive patent portfolio and innovative contributions underscore his commitment to advancing the field of pharmaceuticals. His inventive mindset, coupled with his collaborative spirit, continues to drive him towards pioneering solutions that have the potential to positively impact the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…